Fracture Healing Clinical Trial
Official title:
A Randomized, Parallel, Two Arm, Unblinded Single-center Study of the Effects of Patient-provided Feedback on Fracture Healing and Weight-bearing Status in Orthopedic Patients Undergoing Operative Fixation or Non-operative Treatment of Isolated Tibial Plateau, Pilon, and Other Ankle Fractures
NCT number | NCT05825079 |
Other study ID # | 22-01427 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | June 9, 2023 |
Est. completion date | November 1, 2024 |
The goal of this study is to determine if weight-bearing crutch technology that delivers active feedback to patients during their treatment will impact patient compliance with physician instructions.
Status | Recruiting |
Enrollment | 50 |
Est. completion date | November 1, 2024 |
Est. primary completion date | November 1, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Willing and able to participate in study and complete consent - Will undergo treatment of an isolated tibial plateau, pilon, or ankle fracture and placed in a non-weightbearing status with the use of crutches at NYU. - Have access and use of a mobile phone (exclusively iOS and/or Android devices) Exclusion Criteria: - Patients with concomitant TBI - Polytrauma patients - Pathologic fractures - Prisoners |
Country | Name | City | State |
---|---|---|---|
United States | NYU Langone Health | New York | New York |
Lead Sponsor | Collaborator |
---|---|
NYU Langone Health | ComeBack Mobility |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Percent (%) Change in Average Weight On Crutch from Week 2 to Week 12 | Average weight put on crutch measured using the Smart Crutch Tip. | Week 2, Week 12 | |
Secondary | Time to Recovery | Measured as the duration of time from treatment (operative or non-operative) to recovery. | Up to Week 12 | |
Secondary | Change in Visual Analogue Scale (VAS) - Pain Score from Baseline to Week 12 | Participants rate pain using a VAS ranging from 0 (no hurt) to 10 (unbearable pain). A decrease in scores indicates pain decreased during the observational period. | Baseline, Week 12 | |
Secondary | Percent (%) of Participants with Injury Complications | Up to Week 12 | ||
Secondary | Percent (%) of Participants who Experience Nonunion/Malunion of Lower Extremity Injury | Nonunion/malunion assessed using radiographic imaging. | Up to Week 12 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00548496 -
A Phase IIa Study Of Men And Post-Menopausal Women With A Fractured Distal Radius
|
Phase 2 | |
Completed |
NCT00907296 -
Study of Romosozumab (AMG 785) in Tibial Diaphyseal Fractures Status Post Intramedullary Nailing
|
Phase 2 | |
Completed |
NCT03286270 -
A mRUS Validation Study for Nail-treated Fractures of Long Bones and a TUS Exploratory Study for Nail and Plate-treated Fractures of Long Bones
|
||
Not yet recruiting |
NCT04533984 -
Fracture Recovery for Returning to Duty (Teriparatide STRONG)
|
Phase 4 | |
Recruiting |
NCT03232216 -
Vitamin D Supplementation and Tibia Fracture. Does it Improve Healing Rate?
|
N/A | |
Recruiting |
NCT04941612 -
Use of the Bioabsorbable Activa IM-Nailâ„¢ in Pediatric Diaphyseal Forearm Fractures
|
N/A | |
Recruiting |
NCT01070576 -
Arginine and Nitric Oxide (NO) Early Prognostic Markers for Non-union Development
|
N/A | |
Completed |
NCT01081678 -
Study To Assess FRacTure Healing With SclerosTin Antibody - Hip
|
Phase 2 | |
Recruiting |
NCT03871322 -
The Vitamin K2 and D3 Intervention Trial in Children and Adolescents With the Low-energy Fractures
|
N/A | |
Terminated |
NCT00435877 -
Procurement of Tissue Samples for Cell Cultures and Analyses
|
||
Completed |
NCT04783337 -
Local Remodelling of Bone Fracture Healing
|
N/A |